Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Breast Neoplasms 17Prostatic Neoplasms 16Neoplasms 7Head and Neck Neoplasms 7Brain Neoplasms 7Glioma 5Colonic Neoplasms 5Squamous Cell Carcinoma of Head and Neck 3Spinal Cord Neoplasms 3Pancreatic Neoplasms 3Lymphoma 3Lung Neoplasms 3Astrocytoma 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Rectal Neoplasms 2Oligodendroglioma 2Neurofibromatosis 1 2Lymphoma, Non-Hodgkin 2Glioblastoma 2Disease 2Central Nervous System Neoplasms 2Carcinoma, Neuroendocrine 2Carcinoma, Hepatocellular 2Vasculitis 1Thoracic Neoplasms 1Thoracic Diseases 1Testicular Neoplasms 1Spinal Diseases 1

Interventions

Magnetic Resonance Imaging 2gallium Ga 68 dotatate 1Radiotherapy 1Radiosurgery 1Positron Emission Tomography Computed Tomography 1Methods 1Lansoprazole 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Neuroendocrine × Magnetic Resonance Imaging × Clear all
NCT07458906 2026-03-09

DLL3-Targeted PET/CT in Neuroendocrine Carcinoma

The First Affiliated Hospital of Xiamen University

Phase NA Recruiting
60 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT01879657 2025-08-06

68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)

Radio Isotope Therapy of America

Phase NA Completed
169 enrolled
Endocrine

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡